Craig C Earle1, Bridget A Neville, Robert Fletcher. 1. Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. craig_earle@dfci.harvard.edu
Abstract
BACKGROUND: Although generally well-adjusted, a subset of cancer survivors have been observed to experience ongoing psychological distress. There has been little study of mental health care utilization among cancer survivors, however. MATERIALS AND METHODS: We identified a cohort of cancer survivors continuously enrolled in a managed care organization who were alive at least 5 years after a diagnosis of cancer and without evidence of recurrence. We matched them each to four controls without a history of cancer based on age, sex, and clinic location. We then obtained their health care claims and evaluated their health care utilization along with explanatory variables such as cancer type, non-cancer comorbid conditions, and types of health care providers seen. RESULTS: One thousand one hundred eleven survivors were matched to 4,444 controls. Cancer survivors were more likely than controls to have a mental health diagnosis (33.5 vs. 30.3%, p < 0.05), accounted for mostly by anxiety and sleep disorders. Other predictors of receiving any mental health diagnosis on multivariable analysis were age: Odds Ratio (OR) 0.99 (95% Confidence Interval (CI) 0.99-0.99) for each year; male sex: OR 0.87 (95% CI 0.77-0.99), and comorbidity: OR 0.56 (95% CI 0.49-0.64) for each point on the Charlson scale. The largest subgroup was breast cancer survivors, who were more likely to have a diagnosis of major affective disorder than were female survivors of other cancers. Survivors had more outpatient medical visits in general (mean 27.4 versus 21.9, p < 0.001) and specifically more mental health visits (2.5 versus 1.7 on average, p < 0.001) than did controls. CONCLUSION: Long-term cancer survivors have increased rates of mental health care utilization. Given the size and growth of the survivor population, this represents a significant amount of ongoing distress with important health resource allocation implications for policy makers.
BACKGROUND: Although generally well-adjusted, a subset of cancer survivors have been observed to experience ongoing psychological distress. There has been little study of mental health care utilization among cancer survivors, however. MATERIALS AND METHODS: We identified a cohort of cancer survivors continuously enrolled in a managed care organization who were alive at least 5 years after a diagnosis of cancer and without evidence of recurrence. We matched them each to four controls without a history of cancer based on age, sex, and clinic location. We then obtained their health care claims and evaluated their health care utilization along with explanatory variables such as cancer type, non-cancer comorbid conditions, and types of health care providers seen. RESULTS: One thousand one hundred eleven survivors were matched to 4,444 controls. Cancer survivors were more likely than controls to have a mental health diagnosis (33.5 vs. 30.3%, p < 0.05), accounted for mostly by anxiety and sleep disorders. Other predictors of receiving any mental health diagnosis on multivariable analysis were age: Odds Ratio (OR) 0.99 (95% Confidence Interval (CI) 0.99-0.99) for each year; male sex: OR 0.87 (95% CI 0.77-0.99), and comorbidity: OR 0.56 (95% CI 0.49-0.64) for each point on the Charlson scale. The largest subgroup was breast cancer survivors, who were more likely to have a diagnosis of major affective disorder than were female survivors of other cancers. Survivors had more outpatient medical visits in general (mean 27.4 versus 21.9, p < 0.001) and specifically more mental health visits (2.5 versus 1.7 on average, p < 0.001) than did controls. CONCLUSION: Long-term cancer survivors have increased rates of mental health care utilization. Given the size and growth of the survivor population, this represents a significant amount of ongoing distress with important health resource allocation implications for policy makers.
Authors: Nancy L Keating; Marie Nørredam; Mary Beth Landrum; Haiden A Huskamp; Ellen Meara Journal: J Am Geriatr Soc Date: 2005-12 Impact factor: 5.562
Authors: Edward H Wagner; Sarah M Greene; Gene Hart; Terry S Field; Suzanne Fletcher; Ann M Geiger; Lisa J Herrinton; Mark C Hornbrook; Christine C Johnson; Judy Mouchawar; Sharon J Rolnick; Victor J Stevens; Stephen H Taplin; Dennis Tolsma; Thomas M Vogt Journal: J Natl Cancer Inst Monogr Date: 2005
Authors: Lone Ross; Christoffer Johansen; Susanne Oksbjerg Dalton; Lene Mellemkjaer; Lars H Thomassen; Preben Bo Mortensen; Jørgen H Olsen Journal: N Engl J Med Date: 2003-08-14 Impact factor: 91.245
Authors: Joseph A Greer; Jessica M Solis; Jennifer S Temel; Inga T Lennes; Holly G Prigerson; Paul K Maciejewski; William F Pirl Journal: Psychosomatics Date: 2011 Sep-Oct Impact factor: 2.386
Authors: Jaya S Khushalani; Jin Qin; John Cyrus; Natasha Buchanan Lunsford; Sun Hee Rim; Xuesong Han; K Robin Yabroff; Donatus U Ekwueme Journal: Expert Rev Pharmacoecon Outcomes Res Date: 2018-06-20 Impact factor: 2.217
Authors: Zev M Nakamura; Emily M Damone; Hannah P Herrick; Kirsten A Nyrop; Allison M Deal; A Tucker Brenizer; Hyman B Muss Journal: Support Care Cancer Date: 2022-01-19 Impact factor: 3.359
Authors: Michael J Raphael; Rebecca Griffiths; Yingwei Peng; Sumit Gupta; D Robert Siemens; Claudio Soares; Christopher M Booth Journal: J Natl Cancer Inst Date: 2021-09-04 Impact factor: 13.506
Authors: Addie C Wootten; Jo-Anne M Abbott; Katherine E Chisholm; David W Austin; Britt Klein; Marita P McCabe; Denny Meyer; Anthony J Costello; Declan G Murphy Journal: BMC Cancer Date: 2014-02-11 Impact factor: 4.430